Foxconn's Gou hopes for up to 9 million BioNTech COVID-19 shots for Taiwan this year

Writing on his Facebook page, Gou said the second batch of vaccines should arrive before the end of the week, with the third batch coming around the middle of the month."Following on, it is estimated 700,000 to 800,000 doses per week will come as weekly arrivals, so the target of 8 million to 9 million doses this year will be reached as soon as possible, but we are also working hard to get more to Taiwan this year," he added. BioNTech declined to comment on future deliveries, but noted the first batch had arrived already and Taiwan was working on its distribution plan. Gou was not able to be at the airport to welcome the first batch as he was in quarantine after returning from a trip to Europe. He said that "at the moment" there were no plans for him to receive the second batch in person to "avoid dragging in lots of people". Taiwan is getting the shots, jointly developed with Pfizer, earlier than expected as a delay in regulatory approval of the shot for use in mainland China made a surplus available for the island. The vaccine is approved for use in Chinese-run Hong Kong and Macau. Taiwan's COVID-19 pandemic is well under control, with a vaccination programme proceeding smoothly, though only around 5 per cent of the population are fully inoculated.

Foxconn's Gou hopes for up to 9 million BioNTech COVID-19 shots for Taiwan this year

Writing on his Facebook page, Gou said the second batch of vaccines should arrive before the end of the week, with the third batch coming around the middle of the month.

"Following on, it is estimated 700,000 to 800,000 doses per week will come as weekly arrivals, so the target of 8 million to 9 million doses this year will be reached as soon as possible, but we are also working hard to get more to Taiwan this year," he added.

BioNTech declined to comment on future deliveries, but noted the first batch had arrived already and Taiwan was working on its distribution plan.

Gou was not able to be at the airport to welcome the first batch as he was in quarantine after returning from a trip to Europe.

He said that "at the moment" there were no plans for him to receive the second batch in person to "avoid dragging in lots of people".

Taiwan is getting the shots, jointly developed with Pfizer, earlier than expected as a delay in regulatory approval of the shot for use in mainland China made a surplus available for the island. The vaccine is approved for use in Chinese-run Hong Kong and Macau.

Taiwan's COVID-19 pandemic is well under control, with a vaccination programme proceeding smoothly, though only around 5 per cent of the population are fully inoculated.